Your browser doesn't support javascript.
loading
Teriparatide therapy and beta-tricalcium phosphate enhance scaffold reconstruction of mouse femoral defects.
Jacobson, Justin A; Yanoso-Scholl, Laura; Reynolds, David G; Dadali, Tulin; Bradica, Gino; Bukata, Susan; Puzas, Edward J; Zuscik, Michael J; Rosier, Randy; O'Keefe, Regis J; Schwarz, Edward M; Awad, Hani A.
Afiliación
  • Jacobson JA; The Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, New York, USA.
Tissue Eng Part A ; 17(3-4): 389-98, 2011 Feb.
Article en En | MEDLINE | ID: mdl-20807012
ABSTRACT
To investigate the efficacy of endocrine parathyroid hormone treatment on tissue-engineered bone regeneration, massive femoral defects in C57Bl/6 mice were reconstructed with either 1000 or 8515 poly-lactic acid (PLA)/beta-tricalcium phosphate (ß-TCP) scaffolds (hereafter PLA or PLA/ßTCP, respectively), which were fabricated with low porosity (<30%) to improve their structural rigidity. Experimental mice were treated starting at 1 week postop with daily subcutaneous injections of 40 µg/kg teriparatide until sacrifice at 9 weeks, whereas control mice underwent the same procedure but were injected with sterile saline. Bone regeneration was assessed longitudinally using planar X-ray and quantitative microcomputed tomography, and the reconstructed femurs were evaluated at 9 weeks either histologically or biomechanically to determine their torsional strength and rigidity. Teriparatide treatment increased bone volume and bone mineral content significantly at 6 weeks and led to enhanced trabeculated bone callus formation that appeared to surround and integrate with the scaffold, thereby establishing union by bridging bone regeneration across the segmental defect in 30% of the reconstructed femurs, regardless of the scaffold type. However, the bone volume and mineral content in the PLA reconstructed femurs treated with teriparatide was reduced at 9 weeks to control levels, but remained significantly increased in the PLA/ßTCP scaffolds. Further, bridged teriparatide-treated femurs demonstrated a prototypical brittle bone torsion behavior, and were significantly stronger and stiffer than control specimens or treated specimens that failed to form bridging bone union. Taken together, these observations suggest that intermittent, systemic parathyroid hormone treatment can enhance bone regeneration in scaffold-reconstructed femoral defects, which can be further enhanced by mineralized (ßTCP) particles within the scaffold.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fosfatos de Calcio / Sustitutos de Huesos / Teriparatido / Andamios del Tejido / Fracturas del Fémur Límite: Animals Idioma: En Revista: Tissue Eng Part A Asunto de la revista: BIOTECNOLOGIA / HISTOLOGIA Año: 2011 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fosfatos de Calcio / Sustitutos de Huesos / Teriparatido / Andamios del Tejido / Fracturas del Fémur Límite: Animals Idioma: En Revista: Tissue Eng Part A Asunto de la revista: BIOTECNOLOGIA / HISTOLOGIA Año: 2011 Tipo del documento: Article País de afiliación: Estados Unidos